Wearable Injector MarketSize and Trends

Strategies to improve drug delivery system through the introduction of new wearable injectors is expected to propel the growth of wearable injector market

In 2015, Unilife Corporation introduced Imperium, which is an instant patch pump used for insulin. Imperium is a subcutaneous insulin infusion, disposable, prefilled, and multi-day wearable insulin pump. It has various features that include data connectivity for app to constantly remind and update wireless connectivity such as Bluetooth LE. It also provide real-time access to healthcare provider to track the insulin therapy of each patient.

In 2014, Enable Injections LLC has signed an agreement with CSL Behring to develop novel drug delivery devices. Enable Injectors intent to improve comfort, convenience, and compliance administrative device for the patients with rare diseases.

Enable Injection LLC and Flex entered in agreement to develop and manufacture wearable medical device in 2016. Enable and Flex aims to develop subcutaneous pain-free injection technology with features such as Bluetooth connectivity, monitoring system with smartphone app, mix automation, and passive warming system.

Unilife Corporation entered in an agreement with Amgen to develop customized wearable injectors in 2016. Unilife has granted exclusive rights to Amgen for Unilife’s wearable injectors, with only selected drug classes are used for wearable injector device. Furthermore, Unilife also granted some non-exclusive rights to Amgen for its delivery system of certain therapeutic area that include inflammation, nephrology, oncology, bone health, neuroscience, and cardiovascular.